Stevens-Johnson syndrome associated with reduced tear production complicating the use of cetuximab and panitunumab.

Authors :: Pantano F
Silletta M
Iovieno A
Vincenzi B
Santini D
Galluzzo S
Bonini S
Tonini G
Source :: International journal of colorectal disease [Int J Colorectal Dis] 2009 Oct; Vol. 24 (10), pp. 1247-8. Date of Electronic Publication: 2009 Feb 19.
Publication Year :: 2009

Subjects :: Antibodies, Monoclonal therapeutic use
Antibodies, Monoclonal, Humanized
Cetuximab
Female
Humans
Lung Neoplasms drug therapy
Lung Neoplasms secondary
Middle Aged
Antibodies, Monoclonal adverse effects
Stevens-Johnson Syndrome etiology
Tears metabolism

Full Text Access

Tools